Dermbits

Dermbits

Welcome to Dermbits! Watch short videos of KOLs answering your questions
What can patients with atopic dermatitis expect in terms of long-term efficacy and sustained symptom control with lebrikizumab treatment?
0:37
Nov 6, 2024Atopic Dermatitis

What can patients with atopic dermatitis expect in terms of long-term efficacy and sustained symptom control with lebrikizumab treatment?

-

In what ways can dermatologists customize treatment plans when prescribing lebrikizumab?
0:37
Nov 6, 2024Atopic Dermatitis

In what ways can dermatologists customize treatment plans when prescribing lebrikizumab?

-

How can dermatologists effectively position lebrikizumab as a treatment option to patients with atopic dermatitis, considering the variety of other available therapies?
0:33
Nov 6, 2024Atopic Dermatitis

How can dermatologists effectively position lebrikizumab as a treatment option to patients with atopic dermatitis, considering the variety of other available therapies?

-

How should dermatologists manage atopic dermatitis during pregnancy and breastfeeding?
1:35
Nov 6, 2024Atopic Dermatitis

How should dermatologists manage atopic dermatitis during pregnancy and breastfeeding?

-

How should dermatologists approach itch management in patients with severe pruritus due to atopic dermatitis?
1:00
Nov 6, 2024Atopic Dermatitis

How should dermatologists approach itch management in patients with severe pruritus due to atopic dermatitis?

-

Are there specific patient populations who are at higher risk for adverse effects from ixekizumab?
0:35
Nov 1, 2024Psoriasis

Are there specific patient populations who are at higher risk for adverse effects from ixekizumab?

-

What are the considerations for using ixekizumab in patients with a history of serious infections?
0:38
Nov 1, 2024Psoriasis

What are the considerations for using ixekizumab in patients with a history of serious infections?

-

Does patient weight impact the dosing and efficacy of ixekizumab?
0:20
Nov 1, 2024Psoriasis

Does patient weight impact the dosing and efficacy of ixekizumab?

-

What strategies can be used to taper ixekizumab in patients with sustained remission?
0:36
Nov 1, 2024Psoriasis

What strategies can be used to taper ixekizumab in patients with sustained remission?

-

Can ixekizumab therapy lead to sustained remission or disease modification in patients with psoriasis?
0:36
Nov 1, 2024Psoriasis

Can ixekizumab therapy lead to sustained remission or disease modification in patients with psoriasis?

-

Should ixekizumab be used as a monotherapy, or can it be used concomitantly with other therapies?
0:26
Nov 1, 2024Psoriasis

Should ixekizumab be used as a monotherapy, or can it be used concomitantly with other therapies?

-

Are there any special considerations for transitioning patients with psoriasis from other biologic agents to ixekizumab?
0:53
Nov 1, 2024Psoriasis

Are there any special considerations for transitioning patients with psoriasis from other biologic agents to ixekizumab?

-

What factors contribute to the progression from mild to severe psoriasis?
0:31
Nov 1, 2024Psoriasis

What factors contribute to the progression from mild to severe psoriasis?

-

How can early intervention impact the long-term course of psoriasis?
0:31
Nov 1, 2024Psoriasis

How can early intervention impact the long-term course of psoriasis?

-

How can dermatologists encourage a holistic approach to psoriasis treatment, including lifestyle modifications and mental health support?
0:36
Nov 1, 2024Psoriasis

How can dermatologists encourage a holistic approach to psoriasis treatment, including lifestyle modifications and mental health support?

-

How does ixekizumab impact cardiovascular risk factors in patients with psoriasis?
0:47
Oct 18, 2024Psoriasis

How does ixekizumab impact cardiovascular risk factors in patients with psoriasis?

-

What are the long-term outcomes of ixekizumab therapy in terms of durability of response and maintenance of skin clearance?
0:36
Oct 18, 2024Psoriasis

What are the long-term outcomes of ixekizumab therapy in terms of durability of response and maintenance of skin clearance?

-

How does ixekizumab influence the risk of infections in patients with psoriasis?
1:40
Oct 18, 2024Psoriasis

How does ixekizumab influence the risk of infections in patients with psoriasis?

-

Is there any benefit to extending the dosing interval of ixekizumab in patients with stable psoriasis?
1:14
Oct 18, 2024Psoriasis

Is there any benefit to extending the dosing interval of ixekizumab in patients with stable psoriasis?

-

Is there any evidence to suggest ixekizumab is more effective in certain psoriasis phenotypes or patient subgroups?
0:52
Oct 18, 2024Psoriasis

Is there any evidence to suggest ixekizumab is more effective in certain psoriasis phenotypes or patient subgroups?

-

What lifestyle modifications should be recommended to patients receiving ixekizumab?
0:47
Oct 18, 2024Psoriasis

What lifestyle modifications should be recommended to patients receiving ixekizumab?

-

What is the recommended monitoring for patients with psoriasis receiving ixekizumab?
1:02
Oct 18, 2024Psoriasis

What is the recommended monitoring for patients with psoriasis receiving ixekizumab?

-

What is the role of biopsy in confirming a diagnosis of psoriasis?
0:58
Oct 18, 2024Psoriasis

What is the role of biopsy in confirming a diagnosis of psoriasis?

-

What role do patient preferences play in selecting a psoriasis treatment regimen?
1:06
Oct 18, 2024Psoriasis

What role do patient preferences play in selecting a psoriasis treatment regimen?

-